Compare BLTE & SEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLTE | SEB |
|---|---|---|
| Founded | 2018 | 1918 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Farming/Seeds/Milling |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 5.0B |
| IPO Year | 2021 | 1994 |
| Metric | BLTE | SEB |
|---|---|---|
| Price | $146.23 | $4,874.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $198.00 | N/A |
| AVG Volume (30 Days) | ★ 215.5K | 9.2K |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 0.17% |
| EPS Growth | N/A | ★ 467.71 |
| EPS | N/A | ★ 124.24 |
| Revenue | N/A | ★ $5,809,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $492.11 | N/A |
| P/E Ratio | ★ N/A | $40.78 |
| Revenue Growth | N/A | ★ 7.99 |
| 52 Week Low | $56.68 | $2,740.00 |
| 52 Week High | $200.00 | $5,989.37 |
| Indicator | BLTE | SEB |
|---|---|---|
| Relative Strength Index (RSI) | 51.55 | 40.33 |
| Support Level | $130.00 | $4,752.09 |
| Resistance Level | $168.44 | $5,183.91 |
| Average True Range (ATR) | 8.61 | 243.65 |
| MACD | 1.00 | -10.55 |
| Stochastic Oscillator | 75.20 | 3.53 |
Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.
Seaboard Corp is a diversified group of companies that operate in agricultural, energy, and ocean transport businesses. The company is engaged in hog production, biofuel production, and pork processing in the United States; commodity trading and grain processing in Africa and South America; cargo shipping services in the U.S., Caribbean and Central and South America; sugar and alcohol production in Argentina; and electric power generation in the Dominican Republic. It also has an equity method investment in Butterball, LLC, a producer and processor of turkey products. The group's operating segments are; pork, commodity trading and milling, marine, liquid fuels, power, turkey, and others. It operates in 45 countries, with a concentration in the Caribbean, Central and South American region.